Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Comment by kuatoliveson Oct 04, 2016 1:04pm
64 Views
Post# 25307457

RE:RE:RE:RE:Shorts run the show

RE:RE:RE:RE:Shorts run the showIf everyone who bought at lower levels in the last 5 days sold this morning, that would JUST get you to 3M shares, or the volume we're at right now. If you bought before the 26th of Sept you'd still be under water, and if you held through the Yosprala volatility, you're not selling now either, so who's selling at 5.30? It's just an oddball number for so much volume to trade hands.  You'd think these shorters would run out of gas sooner or later; but one thing I know is that the share price will HAVE meet the fundamentals when Q4 numbers are released in 2017, or guidance is provided before then. In fact, I can't see Adams and crew not releasing guidance before the end of this year because they're likely as stumped as the rest of us.  I mean, there's nothing left:

Tribute/Pozen merger.... check.
New Tax domicile..... check.
Yosprala approval ..... check.
Deployed capital into good deals .... check.

I mean, there's nothing left to prove to investors but wheel out the plate of gold.  

??

Head scratcher for sure.
<< Previous
Bullboard Posts
Next >>